{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1695","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1693","results":[{"created":"2020-08-01T17:55:38.319295+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GATA2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: {Leukemia, acute myeloid, susceptibility to}, MIM# 601626; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA2","entity_type":"gene"},{"created":"2020-08-01T17:54:47.543780+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FH as ready","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:54:47.533869+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fh has been classified as Amber List (Moderate Evidence).","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:54:45.422096+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FH were changed from  to Leiomyomatosis and renal cell cancer, MIM# 150800","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:54:18.924830+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.48","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FH was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:53:54.931861+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FH as Amber List (moderate evidence)","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:53:54.923578+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fh has been classified as Amber List (Moderate Evidence).","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:53:33.117693+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FH: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Leiomyomatosis and renal cell cancer, MIM# 150800; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"FH","entity_type":"gene"},{"created":"2020-08-01T17:50:52.548644+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EPCAM as ready","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:50:52.540279+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: epcam has been classified as Red List (Low Evidence).","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:50:49.787080+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EPCAM were changed from  to Colorectal cancer, hereditary nonpolyposis, type 8, MIM# 613244","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:50:11.773013+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.45","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EPCAM was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:49:47.014099+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EPCAM as Red List (low evidence)","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:49:47.004594+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: epcam has been classified as Red List (Low Evidence).","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:49:21.609078+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EPCAM: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Colorectal cancer, hereditary nonpolyposis, type 8, MIM# 613244; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-08-01T17:47:03.012031+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DIS3L2 as ready","entity_name":"DIS3L2","entity_type":"gene"},{"created":"2020-08-01T17:47:03.003510+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dis3l2 has been classified as Green List (High Evidence).","entity_name":"DIS3L2","entity_type":"gene"},{"created":"2020-08-01T17:46:59.034489+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DIS3L2 as Green List (high evidence)","entity_name":"DIS3L2","entity_type":"gene"},{"created":"2020-08-01T17:46:59.022469+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dis3l2 has been classified as Green List (High Evidence).","entity_name":"DIS3L2","entity_type":"gene"},{"created":"2020-08-01T17:46:19.076507+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.42","user_name":"Zornitza Stark","item_type":"entity","text":"gene: DIS3L2 was added\ngene: DIS3L2 was added to Cancer Predisposition_Paediatric. Sources: Expert list\nMode of inheritance for gene: DIS3L2 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: DIS3L2 were set to Perlman syndrome, MIM#\t267000\nReview for gene: DIS3L2 was set to GREEN\nAdded comment: Increased risk of Wilms tumour. \nSources: Expert list","entity_name":"DIS3L2","entity_type":"gene"},{"created":"2020-08-01T17:36:08.147526+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CEBPA as ready","entity_name":"CEBPA","entity_type":"gene"},{"created":"2020-08-01T17:36:08.134613+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cebpa has been classified as Green List (High Evidence).","entity_name":"CEBPA","entity_type":"gene"},{"created":"2020-08-01T17:36:05.957790+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.41","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CEBPA were changed from  to Leukemia, acute myeloid, MIM# 601626","entity_name":"CEBPA","entity_type":"gene"},{"created":"2020-08-01T17:35:48.386279+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.40","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CEBPA were set to ","entity_name":"CEBPA","entity_type":"gene"},{"created":"2020-08-01T17:35:28.004406+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CEBPA was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CEBPA","entity_type":"gene"},{"created":"2020-08-01T17:35:05.698285+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CEBPA: Rating: ; Mode of pathogenicity: None; Publications: 15575056, 32430494, 31309983; Phenotypes: Leukemia, acute myeloid, MIM# 601626; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CEBPA","entity_type":"gene"},{"created":"2020-08-01T17:31:49.652112+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDKN2A as ready","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:31:49.616658+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdkn2a has been classified as Red List (Low Evidence).","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:31:46.457063+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CDKN2A were changed from  to Familial Malignant Melanoma and Tumors of the Nervous system; Familial Uveal Melanoma; Pancreatic cancer","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:31:20.944894+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.37","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CDKN2A was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:31:01.405352+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CDKN2A as Red List (low evidence)","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:31:01.396908+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdkn2a has been classified as Red List (Low Evidence).","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:30:38.477609+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDKN2A: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Familial Malignant Melanoma and Tumors of the Nervous system, Familial Uveal Melanoma, Pancreatic cancer; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDKN2A","entity_type":"gene"},{"created":"2020-08-01T17:24:47.921944+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDK4 as ready","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:24:47.911135+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdk4 has been classified as Red List (Low Evidence).","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:24:45.428645+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CDK4 were changed from  to {Melanoma, cutaneous malignant, 3}, MIM# 609048","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:24:25.232979+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CDK4 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:24:05.245143+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CDK4 as Red List (low evidence)","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:24:05.234614+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdk4 has been classified as Red List (Low Evidence).","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:23:38.898669+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDK4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: {Melanoma, cutaneous malignant, 3}, MIM# 609048; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDK4","entity_type":"gene"},{"created":"2020-08-01T17:20:36.466381+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDH1 as ready","entity_name":"CDH1","entity_type":"gene"},{"created":"2020-08-01T17:20:36.457944+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdh1 has been classified as Green List (High Evidence).","entity_name":"CDH1","entity_type":"gene"},{"created":"2020-08-01T17:20:33.666908+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CDH1 were changed from  to Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, MIM# 137215","entity_name":"CDH1","entity_type":"gene"},{"created":"2020-08-01T17:20:08.830595+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CDH1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDH1","entity_type":"gene"},{"created":"2020-08-01T17:19:42.755071+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDH1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, MIM# 137215; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDH1","entity_type":"gene"},{"created":"2020-08-01T17:18:45.022955+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CDC73 as ready","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:18:44.993810+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdc73 has been classified as Red List (Low Evidence).","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:18:42.790270+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CDC73 were changed from  to Parathyroid carcinoma, MIM# 608266","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:18:20.987990+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.29","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CDC73 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:17:44.953706+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CDC73 as Red List (low evidence)","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:17:44.943357+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cdc73 has been classified as Red List (Low Evidence).","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:17:19.680253+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CDC73: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Parathyroid carcinoma, MIM# 608266; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CDC73","entity_type":"gene"},{"created":"2020-08-01T17:15:50.869145+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BUB1B as ready","entity_name":"BUB1B","entity_type":"gene"},{"created":"2020-08-01T17:15:50.858929+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bub1b has been classified as Green List (High Evidence).","entity_name":"BUB1B","entity_type":"gene"},{"created":"2020-08-01T17:15:47.358166+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BUB1B as Green List (high evidence)","entity_name":"BUB1B","entity_type":"gene"},{"created":"2020-08-01T17:15:47.349906+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bub1b has been classified as Green List (High Evidence).","entity_name":"BUB1B","entity_type":"gene"},{"created":"2020-08-01T17:15:25.728393+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"gene: BUB1B was added\ngene: BUB1B was added to Cancer Predisposition_Paediatric. Sources: Expert list\nMode of inheritance for gene: BUB1B was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: BUB1B were set to 31081598; 31053147\nPhenotypes for gene: BUB1B were set to Mosaic variegated aneuploidy syndrome 1, MIM# 257300\nReview for gene: BUB1B was set to GREEN\nAdded comment: Syndrome with increased tumour risk: Wilms tumor, nephroblastoma, rhabdomyosarcoma, leukaemia. \nSources: Expert list","entity_name":"BUB1B","entity_type":"gene"},{"created":"2020-08-01T17:09:07.952664+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3633","user_name":"Zornitza Stark","item_type":"panel","text":"removed gene:BAP1 from the panel","entity_name":null,"entity_type":null},{"created":"2020-08-01T17:07:16.827640+10:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BAP1 as ready","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:07:16.817653+10:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bap1 has been classified as Green List (High Evidence).","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:07:11.708589+10:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BAP1 as Green List (high evidence)","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:07:11.698668+10:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bap1 has been classified as Green List (High Evidence).","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:06:46.319274+10:00","panel_name":"Incidentalome","panel_id":126,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"gene: BAP1 was added\ngene: BAP1 was added to Incidentalome. Sources: Expert list\nMode of inheritance for gene: BAP1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: BAP1 were set to 21941004; 23684012; 21874000; 21874003\nPhenotypes for gene: BAP1 were set to Tumor predisposition syndrome, MIM# 614327\nReview for gene: BAP1 was set to GREEN\nAdded comment: Generally adult onset, high-risk for the development of a variety of tumors, including benign melanocytic tumors as well as several malignant tumors, including uveal melanoma, cutaneous melanoma, malignant mesothelioma on exposure to asbestos, and other cancer types, such as lung adenocarcinoma, meningioma, and renal cell carcinoma \nSources: Expert list","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:04:46.313103+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: BAP1 as ready","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:04:46.303066+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bap1 has been classified as Red List (Low Evidence).","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:03:54.900066+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: BAP1 were changed from  to Tumor predisposition syndrome, MIM# 614327","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:03:38.929765+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: BAP1 were set to ","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:03:14.843457+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: BAP1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:02:34.475788+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: BAP1 as Red List (low evidence)","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:02:34.467442+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: bap1 has been classified as Red List (Low Evidence).","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T17:02:12.603899+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: BAP1: Rating: RED; Mode of pathogenicity: None; Publications: 21941004, 23684012, 21874000, 21874003; Phenotypes: Tumor predisposition syndrome, MIM# 614327; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"BAP1","entity_type":"gene"},{"created":"2020-08-01T12:14:09.017936+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: VKORC1 as ready","entity_name":"VKORC1","entity_type":"gene"},{"created":"2020-08-01T12:14:09.009276+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: vkorc1 has been classified as Green List (High Evidence).","entity_name":"VKORC1","entity_type":"gene"},{"created":"2020-08-01T12:14:02.899478+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: VKORC1 as Green List (high evidence)","entity_name":"VKORC1","entity_type":"gene"},{"created":"2020-08-01T12:14:02.887984+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: vkorc1 has been classified as Green List (High Evidence).","entity_name":"VKORC1","entity_type":"gene"},{"created":"2020-08-01T12:13:49.553746+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"gene: VKORC1 was added\ngene: VKORC1 was added to Pharmacogenomics_Paediatric. Sources: Expert list\nMode of inheritance for gene: VKORC1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: VKORC1 were set to 21900891; 28198005\nPhenotypes for gene: VKORC1 were set to Warfarin resistance, MIM#\t122700\nReview for gene: VKORC1 was set to GREEN\nAdded comment: Sources: Expert list","entity_name":"VKORC1","entity_type":"gene"},{"created":"2020-08-01T12:11:44.251749+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP2C9 were set to 25099164","entity_name":"CYP2C9","entity_type":"gene"},{"created":"2020-08-01T12:11:33.356156+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CYP2C9: Changed publications: 25099164, 21900891, 28198005","entity_name":"CYP2C9","entity_type":"gene"},{"created":"2020-08-01T12:10:40.160100+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP3A5 were set to ","entity_name":"CYP3A5","entity_type":"gene"},{"created":"2020-08-01T12:10:30.383456+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.29","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CYP3A5: Changed publications: 25801146","entity_name":"CYP3A5","entity_type":"gene"},{"created":"2020-08-01T12:09:13.133121+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.29","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CYP2C9 were set to ","entity_name":"CYP2C9","entity_type":"gene"},{"created":"2020-08-01T12:09:01.248631+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CYP2C9: Changed publications: 25099164","entity_name":"CYP2C9","entity_type":"gene"},{"created":"2020-08-01T12:08:31.230049+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HLA-B were set to 25099164; 23695185","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:08:17.878817+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: HLA-B: Changed publications: 25099164, 23695185, 29392710","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:07:53.079842+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TPMT were set to ","entity_name":"TPMT","entity_type":"gene"},{"created":"2020-08-01T12:07:42.599139+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: TPMT: Changed publications: 21270794, 23422873, 30447069","entity_name":"TPMT","entity_type":"gene"},{"created":"2020-08-01T12:07:01.119143+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NUDT15 were set to ","entity_name":"NUDT15","entity_type":"gene"},{"created":"2020-08-01T12:06:48.816243+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: NUDT15: Changed publications: 21270794, 23422873, 30447069","entity_name":"NUDT15","entity_type":"gene"},{"created":"2020-08-01T12:05:51.151034+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: HLA-B: Changed publications: 25099164, 23695185","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:05:38.677576+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HLA-B were set to 25099164","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:05:20.419997+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: HLA-B: Changed publications: 23695185","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:04:52.997463+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HLA-B were set to ","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:04:42.869048+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: HLA-B: Changed publications: 25099164","entity_name":"HLA-B","entity_type":"gene"},{"created":"2020-08-01T12:02:30.809438+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CACNA1S as ready","entity_name":"CACNA1S","entity_type":"gene"},{"created":"2020-08-01T12:02:30.799290+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacna1s has been classified as Green List (High Evidence).","entity_name":"CACNA1S","entity_type":"gene"},{"created":"2020-08-01T12:02:26.544595+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CACNA1S as Green List (high evidence)","entity_name":"CACNA1S","entity_type":"gene"},{"created":"2020-08-01T12:02:26.501069+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacna1s has been classified as Green List (High Evidence).","entity_name":"CACNA1S","entity_type":"gene"},{"created":"2020-08-01T12:02:17.531608+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CACNA1S was added\ngene: CACNA1S was added to Pharmacogenomics_Paediatric. Sources: Expert list\nMode of inheritance for gene: CACNA1S was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: CACNA1S were set to 30499100\nPhenotypes for gene: CACNA1S were set to {Malignant hyperthermia susceptibility 5}, MIM#\t601887\nReview for gene: CACNA1S was set to GREEN\nAdded comment: Two variants, c.520C>T; p.(Arg174Trp) and 3257G>A; p.(Arg1086His) have high level of evidence. \nSources: Expert list","entity_name":"CACNA1S","entity_type":"gene"},{"created":"2020-08-01T11:57:54.989483+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RYR1 were set to ","entity_name":"RYR1","entity_type":"gene"},{"created":"2020-08-01T11:57:42.891502+10:00","panel_name":"Pharmacogenomics_Paediatric","panel_id":3271,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: RYR1: Changed publications: 30499100; Changed phenotypes: {Malignant hyperthermia susceptibility 1} 145600","entity_name":"RYR1","entity_type":"gene"}]}